Net delta exposure for Madrigal Pharmaceuticals Inc (MDGL) options was -$1.39M per 1% move at the Nov 4, 2026 close. It has been positive on 18 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $97.28M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for MDGL, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for MDGL, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for MDGL, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
MDGL Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is MDGL delta exposure positive or negative?
Madrigal Pharmaceuticals net delta exposure was negative on Nov 4, 2026, at -$1.39M. It has been positive on 18 of the last 20 trading days.
How has MDGL delta exposure changed recently?
Madrigal Pharmaceuticals net delta exposure went from $97.28M on Oct 7, 2026 to -$1.39M on Nov 4, 2026. See the MDGL delta exposure history for a longer view.
What is Madrigal Pharmaceuticals Inc?
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver...